Bridging population pharmacokinetic and semimechanistic absorption modeling of APX3330.

Silva, Larissa L; Stratford, Robert E; Messmann, Richard; Kelley, Mark R; Quinney, Sara K

Silva, Larissa L; Stratford, Robert E; Messmann, Richard; Kelley, Mark R; Quinney, Sara K.

Afiliación

Silva LL; Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indiana, Indianapolis, USA.
Stratford RE; Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indiana, Indianapolis, USA.
Messmann R; Apexian Pharmaceuticals, Indianapolis, Indiana, USA.
Kelley MR; Departments of Biochemistry and Molecular Biology, and Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Quinney SK; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA.

CPT Pharmacometrics Syst Pharmacol ; 13(1): 106-117, 2024 Jan.

Article en En | MEDLINE | ID: mdl-37884051

Asunto(s)

Hidroquinonas; Neoplasias; Humanos; Masculino; Administración Oral; Inhibidores de la Angiogénesis; Quinonas

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hidroquinonas / Neoplasias Límite: Humans / Male Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google